New Delhi : The Technology Development Board (TDB), Department of Science and Technology, Government of India, has signed an agreement with M/s Primary Healthtech Pvt. Ltd., New Delhi, for the project titled “IoT-enabled Point-of-care Blood Testing Device for Affordable and Accessible Healthcare powered by AI/ML algorithms.”
Founded by Mr. Sahil Jagnani and Mr. Ankit Choudhury, alumni of IIT Guwahati, the company emerged from a multidisciplinary team of doctors, researchers, entrepreneurs, professors, and students working to develop affordable diagnostic technologies for underserved populations. Their collaborative R&D, initially supported by BIRAC, led to the creation of the Mobilab device—a portable, battery-operated clinical chemistry analyzer, IoT-enabled and powered by AI/ML algorithms, capable of testing over 25 parameters related to kidney, liver, heart, vitamins, and cancer.
The company holds a patent for “A transmittance-based system/kit for point-of-care quantification” transferred from IIT Guwahati and has filed over six additional patent applications related to integrated mixers, assay development, centrifuges, and proprietary optical systems. The device has already undergone trials on 10,000 patients and recently received a CDSCO manufacturing license.
The project will focus on enhancing the current prototype (M1) to perform five tests simultaneously, reducing patient waiting time, and setting up commercial-scale manufacturing. This next-generation Mobilab will include tests such as Hemoglobin, Creatinine, Bilirubin, Cholesterol, Triglycerides, Uric Acid, Glucose, and GGT, among others.
Speaking on the occasion, Sh. Rajesh Kumar Pathak, Secretary, TDB, stated:
“Ensuring quality healthcare access in rural and remote regions is a national priority. This project not only addresses affordability and accessibility but also demonstrates India’s capability in developing indigenous, AI-powered diagnostic solutions for primary healthcare.”
The promoters of Primary Healthtech Pvt. Ltd. expressed their gratitude, saying:
“TDB’s support will accelerate our journey from lab innovation to large-scale deployment. With Mobilab, we envision bridging the healthcare gap for rural and underserved communities, ensuring that advanced diagnostics are available at the point of care, anywhere in India.”
This collaboration underscores TDB’s commitment to fostering indigenous healthcare innovations aligned with Atmanirbhar Bharat and advancing India’s presence in affordable medical technologies globally.
